Literature DB >> 310517

Effective subunit vaccines against an enveloped animal virus.

B Morein, A Helenius, K Simons, R Pettersson, L Kääriäinen, V Schirrmacher.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 310517     DOI： 10.1038/276715a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  18 in total

1.  Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

Authors:  L E Henderson; R Sowder; T D Copeland; S Oroszlan; L O Arthur; W G Robey; P J Fischinger
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

2.  Interaction of viral envelope glycoproteins with fibronectin.

Authors:  I Julkunen; A Hautanen; J Keski-Oja
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

3.  In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.

Authors:  P T Naylor; H S Larsen; L Huang; B T Rouse
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 4.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

5.  Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.

Authors:  L O Arthur; J W Bess; D J Waters; S W Pyle; J C Kelliher; P L Nara; K Krohn; W G Robey; A J Langlois; R C Gallo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

Authors:  M Villacres-Eriksson; M Bergström-Mollaoglu; H Kåberg; K Lövgren; B Morein
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.

Authors:  J R North; A J Morgan; J L Thompson; M A Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  The glycoprotein of measles virus. External radioactive labelling of its carbohydrate and partial characterization of the glycopeptide.

Authors:  O Anttonen; M Jokinen; A Salmi; R Vainionpää; C G Gahmberg
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

9.  Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins.

Authors:  F X Heinz; W Tuma; C Kunz
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice.

Authors:  J J Bergers; W Den Otter; H F Dullens; J W De Groot; P A Steerenberg; M W Mimpen; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.